Latest Transformation News

Domain Holdings Australia has confirmed a one-week delay in the implementation of its proposed CoStar scheme of arrangement, now set for 27 August 2025.

Cobalt Blue Holdings reveals promising engineering upgrades and exploration success at its Halls Creek Project, targeting enhanced margins and extended mine life through silver recovery, cobalt credits, and new copper discoveries.

HeraMED advances AI-driven maternity care partnerships and strengthens its US commercial team, navigating policy uncertainties while progressing its global expansion and funding strategies.

HeraMED Limited has raised $1.98 million through a discounted share placement to fund its digital maternity care platform's commercial growth across the US, Australia, and Europe.

Havilah Resources has struck a binding deal with Heavy Rare Earths, granting earn-in rights to its Prospect Hill tin project with a $1.5 million exploration commitment over three years. The arrangement allows Havilah to focus on its copper assets while retaining significant upside exposure.

Chilwa Minerals has raised A$4.1 million through a private placement to fast-track exploration and development at its multi-commodity Chilwa Project in Malawi, with directors backing the raise subject to shareholder approval.

Javelin Minerals has announced a significant 15% increase in recoverable gold ounces at its Eureka Gold Project, alongside a 32% rise in grade, setting the stage for enhanced production and cashflow in 2026.

Imagion Biosystems has raised A$3.5 million through a placement to fund its Phase 2 clinical trial for HER2+ Breast Cancer in the US, marking a significant step in advancing its proprietary MagSense® imaging technology.

Siren Gold has appointed seasoned mining executive Zane Padman as CEO, signaling a strategic push to unlock the potential of its Sams Creek gold project. This leadership change aims to accelerate development amid strong market conditions for gold and antimony.

Somerset Minerals has confirmed significant near-surface copper mineralisation at its Coppermine Project in Nunavut, Canada, with assays revealing thick, high-grade intercepts. The company is gearing up for an expanded exploration phase to unlock further district-scale potential.

Rhythm Biosciences has advanced its ColoSTAT® diagnostic kits to final production validation, demonstrating consistent detection of colorectal cancer across all stages in a pivotal study. The company is gearing up for regulatory submission and commercial launch later this year.

Augustus Minerals has appointed Dr James Warren as its new CEO, bringing a wealth of exploration and corporate growth experience to lead its promising Western Australian projects. This leadership change signals a strategic push towards advancing drilling campaigns and unlocking shareholder value.